DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$2.07
+0.02 (+0.98%)
Open$2.02
Previous Close$2.05
Day High$2.14
Day Low$2.02
52W High$9.19
52W Low$1.27
Volume—
Avg Volume202.7K
Market Cap32.51M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+99.0% upside
Current
$2.07
$2.07
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.38M | 2.95M | 6.37M |
| Net Income | -17,954,430 | -34,468,828 | 1.14M |
| Profit Margin | -1,300.7% | -1,235.6% | 17.9% |
| EBITDA | -15,969,646 | -32,361,697 | 1.58M |
| Free Cash Flow | — | — | 772.3K |
| Rev Growth | -53.1% | -53.1% | +7.5% |
| Debt/Equity | 2.42 | 2.42 | 0.72 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |